By 2023, Nacimbio holding has delivered nearly 300,000 vaccine doses for the prevention of measles, rubella, and mumps. To maintain a steady supply and minimize any risks of shortages, these vaccines will be promptly and continuously distributed to the public as soon as they are made available – as Ministry of Industry and Trade of Russia said.
“Nacimbio JSC, as part of the execution of government contracts with the Federal Institution “FCPiLO” of the Ministry of Health of Russia, in 2023 supplied immunobiological drugs to the constituent entities of the Russian Federation: almost 300 thousand doses of vaccine for the prevention of measles, rubella and mumps have already been supplied. <…> In order to prevent defects, the shipment of vaccines will be carried out on an ongoing basis as they are released into civilian circulation with an even distribution across the constituent entities of the Russian Federation,” the ministry said.
They have also highlighted that by December 22nd, an additional 344,000 doses of the comprehensive vaccine are anticipated to be delivered, along with 38,000 doses of the mumps prevention vaccine and 54,000 doses of the measles and mumps prevention vaccine. “The remaining volume of vaccines will be shipped to the regions by the end of the first quarter of 2024,” the Ministry of Industry and Trade added.
